| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Jones James is a Director at CPIX. Recent filings cover 249 purchases and 0 sales. Those positions are worth an estimated $373K at current prices.
Our model assigns Jones James a middling insider score of 55/100, based on 470 past trades. Over a 12-month horizon, 24.3% of those trades were profitable, with an average 12-month return of +0.2%.
Jones James's largest disclosed position is in CPIX as Director, worth about $373K. Net of sales, the recent Form 4 record there shows accumulation of 7,210 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Director | Buy | 882 | $2.83 | $2,495.22 | +0.3% | +76.5% | -10.1% | |
| Aug 31, 2021 | CPIX Cumberland Pharmaceuticals Inc | Director | Buy | 882 | $2.98 | $2,626.68 | +0.3% | -23.6% | -18.4% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Director | Buy | 714 | $3.32 | $2,367.54 | +0.3% | -18.5% | -30.2% |